Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

NCT01227213 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01227213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
November 30, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, insulin sensitivity, renal cell carcinoma, renal function